Adamantidou C, Ahn S, Rousseau M, Gruson D. Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay.
Acta Cardiol 2022;
77:176-179. [PMID:
34078238 DOI:
10.1080/00015385.2021.1903195]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Natriuretic peptides are widely used in clinical practice as cardiac markers for early diagnosis, prognosis and for the monitoring of treatment efficiency of heart Failure (HF). According to the clinical relevance of natriuretic peptides testing, it is important to assess the performances of novel platform for testing. Our study showed the overall good performances of a new NT-proBNP ABEI-based automated immunoassay.
Collapse